Surgery for hilar cholangiocarcinoma: The Leeds experience

European Journal of Surgical Oncology

Volumn 34, Issue 7, 2008, Pages 787-794

  Hidalgo, E ^a   Asthana, S ^a   Nishio, H ^a   Wyatt, J ^a   Toogood, G J ^a   Prasad, K R ^a   Lodge, J P A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Hilar cholangiocarcinoma; Radical resection; Surgery

Indexed keywords

ARTERY SURGERY; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONFIDENCE INTERVAL; DEATH; DEMOGRAPHY; HAZARD RATIO; HEPATIC ARTERY; HISTOPATHOLOGY; HUMAN; INOPERABLE CANCER; LIVER GRAFT; LIVER RESECTION; LIVER TRANSPLANTATION; LYMPHADENECTOMY; METASTASIS; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; VEIN SURGERY;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; GREAT BRITAIN; HEPATECTOMY; HUMANS; LIKELIHOOD FUNCTIONS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 44949175030     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.10.005     Document Type: Article

References (47)

1. Parker S.L., Tong T., Bolden S., and Wingo P.A. Cancer statistics. CA Cancer J Clin 46 1 (1996) 5-27
2. Burke E.C., Jarnagin W.R., Hochwald S.N., Pisters P.W., Fong Y., and Blumgart L.H. Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 228 3 (1998) 385-394
3. Nagorney D.M., Donohue J.H., Farnell M.B., Schleck C.D., and Ilstrup D.M. Outcomes after curative resections of cholangiocarcinoma. Arch Surg 128 8 (1993) 871-877
4. Nakeeb A., Pitt H.A., Sohn T.A., et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumours. Ann Surg 224 4 (1996) 463-473
5. Tompkins R.K., Thomas D., Wile A., and Longmire Jr. W.P. Prognostic factors in bile duct carcinoma: analysis of 96 cases. Ann Surg 194 4 (1981) 447-457
6. Launois B., Reding R., Lebeau G., and Buard J.L. Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers. J Hepatobiliary Pancreat Surg 7 2 (2000) 128-134
7. Taylor-Robinson S.D., Toledano M.B., Arora S., et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 48 6 (2001) 816-820 Erratum in: Gut2001;49(2):315
8. O'Grady J.G. Treatment options for other hepatic malignancies. Liver Transpl 6 6 Suppl. 2 (2000) S23-S29
9. Gores G.J. Early detection and treatment of cholangiocarcinoma. Liver Transpl 6 6 Suppl. 2 (2000) S30-S34
10. Stain S.C., Baer H.U., Dennison A.R., and Blumgart L.H. Current management of hilar cholangiocarcinoma. Surg Gynecol Obstet 175 6 (1992) 579-588
11. De Vreede I., Steers J.L., Burch P.A., et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 6 3 (2000) 317-319
12. Sugiura Y., Nakamura S., Iida S., et al. Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery 115 4 (1994) 445-451
13. Pichlmayr R., Weimann A., Klempnauer J., et al. Surgical treatment in proximal bile duct cancer. A single-centre experience. Ann Surg 224 5 (1996) 628-638
14. Su C.-H., Tsay S.H., Wu C.-C., et al. Factors Influencing Postoperative Morbidity, Mortality, and Survival After Resection for Hilar Cholangiocarcinoma. Ann Surg 223 (1996) 384-394
15. Gerhards M.F., van Gulik T.M., de Wit L.T., Obertop H., and Gouma D.J. Evaluation of morbidity and mortality after resection for hilar holangiocarcinoma-a single centre experience. Surgery 127 4 (2000) 395-404
16. Nimura Y., Kamiya J., Kondo S., et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg 7 2 (2000) 155-162
17. Launois B., Terblanche J., Lakehal M., et al. Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg 230 2 (1999) 266-275
18. Neuhaus P., Jonas S., Bechstein W.O., et al. Extended resections for hilar cholangiocarcinoma. Ann Surg 230 6 (1999) 808-818
19. Miyazaki M., Ito H., Nakagawa K., et al. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg 189 6 (1999) 575-583
20. Lee S.G., Lee Y.J., Park K.M., Hwang S., and Min P.C. One hundred and eleven liver resections for hilar bile duct cancer. J Hepatobiliary Pancreat Surg 7 2 (2000) 135-141
21. Jarnagin W.R., Fong Y., DeMatteo R.P., et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234 4 (2001) 507-517
22. Seyama Y., Kubota K., Sano K., et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 238 1 (2003) 73-83
23. Ebata T., Nagino M., Kamiya J., Uesaka K., Nagasaka T., and Nimura Y. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg 238 5 (2003) 720-727
24. Silva M.A., Tekin K., Aytekin F., Bramhall S.R., Buckels J.A., and Mirza D.F. Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK. Eur J Surg Oncol 31 5 (2005) 533-539
25. Nagino M., Kamiya J., Nishio H., Ebata T., Arai T., and Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 243 3 (2006) 364-372
26. Lillemoe K.D. Preoperative biliary drainage and surgical outcome. Ann Surg 230 2 (1999) 143-144
27. Hochwald S.N., Burke E.C., Jarnagin W.R., Fong Y., and Blumgart L.H. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 134 3 (1999) 261-266
28. Takada T. Is preoperative biliary drainage necessary according to evidence-based medicine?. J Hepatobiliary Pancreat Surg 8 1 (2001) 58-64
29. Cherqui D., Benoist S., Malassagne B., Humeres R., Rodriguez V., and Fagniez P.L. Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. Arch Surg 135 3 (2000) 302-308
30. Khan S.A., Davidson B.R., Goldin R., et al. British Society of Gastroenterology. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51 Suppl. 6 (2002) VI1-VI9
31. Robles R., Figueras J., Turrion V.S., et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg 239 2 (2004) 265-271
32. Figueras J., Llado L., Valls C., et al. Changing strategies in diagnosis and management of hilar cholangiocarcinoma. Liver Transpl 6 6 (2000) 786-794
33. Meyer C.G., Penn I., and James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 69 8 (2000) 1633-1637
34. Iwatsuki S., Todo S., Marsh J.W., et al. Treatment of hilar cholangiocarcinoma (Klatskin tumours) with hepatic resection or transplantation. J Am Coll Surg 187 4 (1998) 358-364
35. Starzl T.E., Todo S., Tzakis A., et al. Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg 210 3 (1989) 374-385
36. Rea D.J., Heimbach J.K., Rosen C.B., et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242 3 (2005) 451-458 discussion 458-461
37. Ogura Y., and Kawarada Y. Surgical strategies for carcinoma of the hepatic duct confluence. Br J Surg 85 1 (1998) 20-24
38. Koyama K., Tanaka J., Kato S., and Asanuma Y. New strategy for treatment of carcinoma of the hilar bile duct. Surg Gynecol Obstet 168 6 (1989) 523-530
39. Nimura Y., Hayakawa N., Kamiya J., Kondo S., and Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg 14 4 (1990) 535-543
40. Ogura Y., Mizumoto R., Tabata M., Matsuda S., and Kusuda T. Surgical treatment of carcinoma of the hepatic duct confluence: analysis of 55 resected carcinomas. World J Surg 17 1 (1993) 85-92
41. Tsao J.I., Nimura Y., Kamiya J., et al. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg 232 2 (2000) 166-174
42. Saldinger P.F., and Blumgart L.H. Resection of hilar cholangiocarcinoma-a European and United States experience. J Hepatobiliary Pancreat Surg 7 2 (2000) 111-114
43. Todoroki T., Kawamoto T., et al. Radical resection of hilar bile duct carcinoma and predictors of survival. Br J Surg 87 3 (2000) 306-313
44. Nishio H., Hidalgo E., Hamady Z.Z., et al. Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. Ann Surg 242 2 (2005) 267-275
45. International Union Against Cancer. TNM classification of malignant tumours (2002), Wiley-Liss, New York
46. Kitagawa Y., Nagino M., Kamiya J., et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and para-aortic node dissection. Ann Surg 233 3 (2001) 385-392
47. Uchiyama K., Nakai T., Tani M., et al. Indications for extended hepatectomy in the management of stage IV hilar cholangiocarcinoma. Arch Surg 138 9 (2003) 1012-1016